Rebecca L Rich

Title: Inventor Rebecca L. Rich: Pioneering Collagen-Binding Proteins

Introduction

Rebecca L. Rich is a distinguished inventor based in Salt Lake City, UT, recognized for her contributions to the field of biomedical innovation. With a focus on collagen-binding proteins derived from enterococcal bacteria, her work has significant implications for the treatment and prevention of bacterial infections.

Latest Patents

Rebecca holds two patents, the most recent of which is centered around a collagen-binding MSCRAMM known as Ace. This protein is homologous to the ligand-binding region of Cna, another well-known collagen-binding MSCRAMM. The Ace protein demonstrates a unique ability to inhibit the adhesion of enterococcal bacteria to extracellular matrix proteins, providing a promising avenue for therapeutic intervention against infections caused by these bacteria. Specifically, the N-terminal region of Ace, referred to as the A domain, comprises several tandem repeat units that enhance its binding capabilities. By employing antibodies raised against this protein or its A domain, researchers can effectively prevent the adhesion of enterococcal cells to collagen substrates, thereby contributing to novel strategies for infection management.

Career Highlights

Rebecca's career has been marked by her affiliation with prominent institutions, including the Texas A&M University System and the Massachusetts Institute of Technology (MIT). Her research and innovative contributions have shaped an important area of study, focusing on how specific proteins can be harnessed in medical applications.

Collaborations

Throughout her career, Rebecca has collaborated with notable colleagues in her field, including Bernd Kriekemeyer and Rick T. Owens. These collaborations have undoubtedly facilitated the advancement of her research and the development of her patented technologies.

Conclusion

In summary, Rebecca L. Rich stands out as an innovative inventor whose work on collagen-binding proteins has the potential to revolutionize the understanding and treatment of enterococcal infections. Her contributions to science and medicine underscore the importance of interdisciplinary collaboration in driving technological advancements.